GIST

Oncology·MeSH: Digestive System Neoplasms

10 drugs in development·8 companies·3 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
ayvakit	Blueprint Medicines Corp (BPMC)
qinlock	Deciphera Pharmaceuticals, Inc. (DCPH)

Phase 1(2)

Drug	Company
hqp1351	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
imatinib	Kura Oncology, Inc. (KURA)

Unknown(3)

Drug	Company
lunre+camo	Repare Therapeutics Inc. (RPTX)
null	Neurogene Inc. (NGNE)
rese-cel (resecabtagene autoleucel	Cabaletta Bio, Inc. (CABA)

Phase 1/Phase 2(3)

Drug	Company
dcc-3009	Deciphera Pharmaceuticals, Inc. (DCPH)
inlexisertib	Deciphera Pharmaceuticals, Inc. (DCPH)
THE-630	Theseus Pharmaceuticals, Inc. (THRX)

BioSniper tracks 10 drugs in development for GIST across 8 companies.

There are 3 clinical trials targeting GIST tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.